Efficacy and safety of Symbicort (budesonide/formoterol 80/4.5 mcg, 2 inhal. b.i.d.) compared to Pulmicort (budesonide 100 mcg, 2 inhal. b.i.d.) and Pulmicort (budesonide 100 mcg, 2 inhal. b.i.d.) plus Oxis (formoterol 4.5 mcg, 2 inhal. b.i.d.) all delivered via Turbuhaler in steroid using asthmatic children. A double-blind, double-dummy, randomised, parallel-group, phase III, multicentre 12-week study.

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting ClinicalTrialTransparency@AstraZeneca.com.

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting ClinicalTrialTransparency@AstraZeneca.com.